Jialin Mo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Gene Expression

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Sui, Teng Wang, Yanqing Mei, Ying Zhu, Wenyan Jiang, Jiayi Shen, Siyuan Yan, Wenjie Lu, Ke-Wen Zhao, Jialin Mo, Chaochen Wang, Yujie Tang
Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. Cancer research 84 (16) (2024)
Yi Sui, Teng Wang, Yanqing Mei, Ying Zhu, Wenyan Jiang, Jiayi Shen, Siyuan Yan, Wenjie Lu, Ke-Wen Zhao, Jialin Mo, Chaochen Wang, Yujie Tang
Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. Cancer research 84 (16) (2024)
Yi Sui, Teng Wang, Yanqing Mei, Ying Zhu, Wenyan Jiang, Jiayi Shen, Siyuan Yan, Wenjie Lu, Ke-Wen Zhao, Jialin Mo, Chaochen Wang, Yujie Tang
Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. Cancer research (2024)
Jialin Mo, Kezhe Tan, Yu Dong, Wenjie Lu, Fang Liu, Yanqing Mei, Hongting Huang, Kewen Zhao, Zhibao Lv, Youqiong Ye, Yujie Tang
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex. Oncogene (2022)